Home ETF List About

Portfolio Holdings Detail for ISIN IE000KJPDY61
Stock Name / FundiShares World Equity High Income UCITS ETF USD Inc
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity Type
Entity LEI 549300PZLRJB7M8H1057
ETF TickerWINC(GBP) LSE
ETF TickerWINC.AS(USD) AS
ETF TickerWINC(USD) Euronext Amsterdam

Holdings detail for INCY

Stock NameIncyte Corporation
TickerINCY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45337C1027
LEI549300Z4WN6JVZ3T4680

Show aggregate INCY holdings

News associated with INCY

Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $84.18, changing hands for $84.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-09-18 08:17:02
Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib
(RTTNews) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppurativa (HS). - 2025-09-17 03:26:09
Incyte Corporation (NASDAQ:INCY) Short Interest Update
Incyte Corporation (NASDAQ:INCY – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 9,600,000 shares, an increase of 29.4% from the July 31st total of 7,420,000 shares. Based on an average trading volume of 1,860,000 shares, the […] - 2025-09-11 04:51:36
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Incyte Corporation (NASDAQ:INCY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating on the company. The […] - 2025-08-26 02:32:54
Incyte (NASDAQ:INCY) Given New $73.00 Price Target at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Free Report) had its price objective increased by JPMorgan Chase & Co. from $67.00 to $73.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on INCY. Citigroup upped their price objective on […] - 2025-08-25 03:08:46
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Charles Schwab Investment Management Inc. Purchases 38,962 Shares of Incyte Corporation (NASDAQ:INCY)
Charles Schwab Investment Management Inc. raised its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,682,029 shares of the biopharmaceutical company’s stock after purchasing an additional 38,962 […] - 2025-08-13 05:43:01
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Citigroup Raises Incyte (NASDAQ:INCY) Price Target to $103.00
Incyte (NASDAQ:INCY – Get Free Report) had its price objective lifted by equities researchers at Citigroup from $88.00 to $103.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s target price suggests a potential upside of 37.54% from the […] - 2025-08-01 04:32:55
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Incyte Corporation (NASDAQ:INCY – Get Free Report) have earned a consensus rating of “Hold” from the eighteen research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and five have assigned a buy recommendation to the […] - 2025-08-01 03:04:43
Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $76.09, changing hands for $77.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-07-30 10:12:59
Mutual of America Capital Management LLC Sells 478 Shares of Incyte Corporation (NASDAQ:INCY)
Mutual of America Capital Management LLC lessened its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,719 shares of the biopharmaceutical company’s stock after selling 478 shares during the quarter. […] - 2025-07-22 08:02:58
Incyte Corporation (NASDAQ:INCY) Shares Sold by Ballentine Partners LLC
Ballentine Partners LLC trimmed its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 12.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,686 shares of the biopharmaceutical company’s stock after selling 649 shares during the quarter. Ballentine Partners LLC’s holdings in Incyte were worth $284,000 at the end of the most recent […] - 2025-07-17 05:12:56
Cerity Partners LLC Has $8.04 Million Stock Position in Incyte Corporation (NASDAQ:INCY)
Cerity Partners LLC lifted its holdings in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 103.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 132,703 shares of the biopharmaceutical company’s stock after buying an additional 67,495 shares during the period. Cerity Partners LLC owned […] - 2025-07-16 05:40:51
Incyte (NASDAQ:INCY) Price Target Cut to $67.00 by Analysts at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Get Free Report) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $68.00 to $67.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of […] - 2025-07-16 04:26:52
Sheila A. Denton Sells 599 Shares of Incyte Corporation (NASDAQ:INCY) Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Sheila A. Denton sold 599 shares of the company’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $68.61, for a total value of $41,097.39. Following the completion of the sale, the executive vice president owned 26,504 […] - 2025-07-09 06:12:52
Incyte Corporation (NASDAQ:INCY) EVP Barry P. Flannelly Sells 10,903 Shares of Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Barry P. Flannelly sold 10,903 shares of the stock in a transaction that occurred on Thursday, July 3rd. The shares were sold at an average price of $68.15, for a total transaction of $743,039.45. Following the sale, the executive vice president directly owned 39,744 shares of the […] - 2025-07-08 06:54:44
Incyte Corporation (NASDAQ:INCY) EVP Sells $587,248.55 in Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Vijay K. Iyengar sold 8,617 shares of the company’s stock in a transaction dated Thursday, July 3rd. The stock was sold at an average price of $68.15, for a total transaction of $587,248.55. Following the completion of the sale, the executive vice president directly owned 37,701 shares […] - 2025-07-08 06:20:54
Incyte Corporation (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. trimmed its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 16.8% in the first quarter, Holdings Channel.com reports. The institutional investor owned 7,875 shares of the biopharmaceutical company’s stock after selling 1,592 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $477,000 as of its most recent filing […] - 2025-07-08 04:46:50
Sumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY)
Sumitomo Mitsui Trust Group Inc. increased its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 5.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 473,186 shares of the biopharmaceutical company’s stock after purchasing an additional 25,844 shares […] - 2025-07-03 05:25:07
Incyte Corporation (NASDAQ:INCY) Shares Purchased by Chevy Chase Trust Holdings LLC
Chevy Chase Trust Holdings LLC raised its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 0.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,241 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the quarter. […] - 2025-06-27 05:36:52
Janney Montgomery Scott LLC Boosts Stock Position in Incyte Corporation (NASDAQ:INCY)
Janney Montgomery Scott LLC grew its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 10.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 29,793 shares of the biopharmaceutical company’s stock after purchasing an additional 2,746 shares during the period. Janney Montgomery Scott LLC’s holdings in Incyte were worth $1,804,000 as of its […] - 2025-06-27 04:26:49
State of Alaska Department of Revenue Purchases 590 Shares of Incyte Corporation (NASDAQ:INCY)
State of Alaska Department of Revenue lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 3.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,824 shares of the biopharmaceutical company’s stock after acquiring an additional 590 shares […] - 2025-06-26 05:56:50
Kentucky Retirement Systems Insurance Trust Fund Makes New Investment in Incyte Corporation (NASDAQ:INCY)
Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Incyte Corporation (NASDAQ:INCY – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,624 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. A number […] - 2025-06-26 05:03:09
Incyte Corporation (NASDAQ:INCY) Shares Acquired by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 66.5% during the 1st quarter, HoldingsChannel.com reports. The fund owned 79,735 shares of the biopharmaceutical company’s stock after acquiring an additional 31,851 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Incyte were worth $4,828,000 […] - 2025-06-26 04:30:52
Assenagon Asset Management S.A. Has $536,000 Stock Position in Incyte Corporation (NASDAQ:INCY)
Assenagon Asset Management S.A. raised its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,846 shares of the biopharmaceutical company’s stock after acquiring an additional 2,418 shares during the period. […] - 2025-06-20 04:54:50
Incyte Corporation (NASDAQ:INCY) Shares Sold by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lowered its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 41.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,117 shares of the biopharmaceutical company’s stock after selling 12,867 shares during the period. Exchange Traded Concepts […] - 2025-06-19 05:43:03
Fifth Third Bancorp Has $551,000 Holdings in Incyte Corporation (NASDAQ:INCY)
Fifth Third Bancorp raised its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 9,103 shares of the biopharmaceutical company’s stock after acquiring an additional 179 shares during the quarter. Fifth Third Bancorp’s holdings in Incyte were worth $551,000 at the end of […] - 2025-06-18 04:56:49
Incyte (NASDAQ:INCY) Raised to “Buy” at Stifel Nicolaus
Incyte (NASDAQ:INCY – Get Free Report) was upgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “buy” rating in a research report issued on Monday, MarketBeat reports. The brokerage currently has a $107.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $75.00. Stifel Nicolaus’ price […] - 2025-06-18 02:22:54
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 13:23:43

iShares World Equity High Income UCITS ETF USD Inc INCY holdings

DateNumber of INCY Shares HeldBase Market Value of INCY SharesLocal Market Value of INCY SharesChange in INCY Shares HeldChange in INCY Base ValueCurrent Price per INCY Share HeldPrevious Price per INCY Share Held
2025-11-13 (Thursday)618USD 65,143INCY holding decreased by -1762USD 65,1430USD -1,762 USD 105.409 USD 108.261
2025-11-12 (Wednesday)618USD 66,905INCY holding increased by 62USD 66,9050USD 62 USD 108.261 USD 108.16
2025-11-11 (Tuesday)618USD 66,843INCY holding increased by 1347USD 66,8430USD 1,347 USD 108.16 USD 105.981
2025-11-10 (Monday)618USD 65,496USD 65,4960USD 0 USD 105.981 USD 105.981
2025-11-07 (Friday)618USD 65,496INCY holding increased by 482USD 65,4960USD 482 USD 105.981 USD 105.201
2025-11-06 (Thursday)618USD 65,014INCY holding decreased by -309USD 65,0140USD -309 USD 105.201 USD 105.701
2025-11-05 (Wednesday)618USD 65,323INCY holding increased by 1718USD 65,3230USD 1,718 USD 105.701 USD 102.921
2025-11-04 (Tuesday)618USD 63,605INCY holding increased by 835USD 63,6050USD 835 USD 102.921 USD 101.57
2025-11-03 (Monday)618USD 62,770INCY holding increased by 4999USD 62,7700USD 4,999 USD 101.57 USD 93.4806
2025-10-31 (Friday)618USD 57,771INCY holding increased by 550USD 57,7710USD 550 USD 93.4806 USD 92.5906
2025-10-30 (Thursday)618USD 57,221INCY holding increased by 1490USD 57,2210USD 1,490 USD 92.5906 USD 90.1796
2025-10-29 (Wednesday)618USD 55,731INCY holding decreased by -909USD 55,7310USD -909 USD 90.1796 USD 91.6505
2025-10-28 (Tuesday)618USD 56,640INCY holding decreased by -883USD 56,6400USD -883 USD 91.6505 USD 93.0793
2025-10-27 (Monday)618USD 57,523INCY holding increased by 1112USD 57,5230USD 1,112 USD 93.0793 USD 91.2799
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INCY by Blackrock for IE000KJPDY61

Show aggregate share trades of INCY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-08-12BUY79781.61081.820 81.799USD 65,194 66.91
2025-08-11SELL-82679.19079.720 79.667USD -65,805 66.82 Loss of -10,610 on sale
2025-08-07BUY85078.20078.250 78.245USD 66,508 66.74
2025-08-06BUY85077.65079.430 79.252USD 67,364 66.66
2025-08-04BUY15678.04078.250 78.229USD 12,204 66.48
2025-08-01BUY13475.59075.690 75.680USD 10,141 66.41
2025-07-31BUY13474.89077.460 77.203USD 10,345 66.35
2025-07-30BUY13477.55078.770 78.648USD 10,539 66.26
2025-07-29BUY13477.38077.870 77.821USD 10,428 66.17
2025-07-28SELL-13470.16070.930 70.853USD -9,494 66.14 Loss of -631 on sale
2025-07-22BUY10168.90069.120 69.098USD 6,979 66.12
2025-07-21BUY7967.38068.630 68.505USD 5,412 66.11
2025-07-18BUY7967.86069.430 69.273USD 5,473 66.10
2025-07-17BUY4668.94069.650 69.579USD 3,201 66.07
2025-07-16BUY5569.23069.420 69.401USD 3,817 66.05
2025-07-15BUY6468.25070.150 69.960USD 4,477 66.03
2025-07-14BUY9769.98070.040 70.034USD 6,793 65.99
2025-07-11BUY10868.59069.970 69.832USD 7,542 65.97
2025-07-10BUY10870.34070.620 70.592USD 7,624 65.93
2025-07-09BUY13068.72069.300 69.242USD 9,001 65.91
2025-07-08BUY13067.67068.650 68.552USD 8,912 65.90
2025-07-07BUY17467.27068.250 68.152USD 11,858 65.88
2025-07-04BUY174 68.450* 65.86
2025-07-03BUY17468.45068.960 68.909USD 11,990 65.84
2025-07-02BUY26268.17069.100 69.007USD 18,080 65.82
2025-06-30BUY26268.10068.820 68.748USD 18,012 65.80
2025-06-27BUY26268.37071.120 70.845USD 18,561 65.77
2025-06-26BUY26270.81071.500 71.431USD 18,715 65.73
2025-06-25BUY26267.55069.140 68.981USD 18,073 65.71
2025-06-24BUY26269.01069.540 69.487USD 18,206 65.68
2025-06-23BUY27367.26068.780 68.628USD 18,735 65.66
2025-06-20BUY27368.46069.190 69.117USD 18,869 65.64
2025-06-19BUY273 68.270* 65.61
2025-06-18BUY27368.27069.470 69.350USD 18,933 65.58
2025-06-17BUY27368.81070.890 70.682USD 19,296 65.55
2025-06-16BUY27371.22071.290 71.283USD 19,460 65.49
2025-06-13BUY32867.75068.960 68.839USD 22,579 65.47
2025-06-12BUY27669.22069.540 69.508USD 19,184 65.43
2025-06-11BUY28768.85070.360 70.209USD 20,150 65.40
2025-06-10BUY27470.07070.980 70.889USD 19,424 65.35
2025-06-09BUY27469.89069.960 69.953USD 19,167 65.30
2025-06-06BUY27468.77068.980 68.959USD 18,895 65.27
2025-06-05BUY27467.24067.870 67.807USD 18,579 65.24
2025-06-04BUY29667.42068.450 68.347USD 20,231 65.22
2025-06-03BUY28467.11070.970 70.584USD 20,046 65.20
2025-06-02BUY29565.31065.970 65.904USD 19,442 65.20
2025-05-30BUY29565.06065.770 65.699USD 19,381 65.20
2025-05-29BUY29566.04066.260 66.238USD 19,540 65.19
2025-05-28BUY30664.93065.610 65.542USD 20,056 65.19
2025-05-27BUY30665.35065.800 65.755USD 20,121 65.19
2025-05-26BUY306 64.245* 65.20
2025-05-23BUY30664.25064.570 64.538USD 19,749 65.21
2025-05-22BUY30664.51065.330 65.248USD 19,966 65.22
2025-05-21BUY39464.78065.460 65.392USD 25,764 65.23
2025-05-20BUY28865.30066.110 66.029USD 19,016 65.23
2025-05-19BUY28863.81064.300 64.251USD 18,504 65.24
2025-05-16BUY29963.31063.480 63.463USD 18,975 65.27
2025-05-15BUY29962.76062.990 62.967USD 18,827 65.30
2025-05-14BUY29961.16062.500 62.366USD 18,647 65.36
2025-05-13BUY29960.81061.150 61.116USD 18,274 65.42
2025-05-12BUY29960.85061.410 61.354USD 18,345 65.48
2025-05-09BUY34358.98060.480 60.330USD 20,693 65.56
2025-05-08BUY29159.73059.990 59.964USD 17,450 65.64
2025-05-07BUY29159.55060.070 60.018USD 17,465 65.73
2025-05-06BUY1,42959.61062.510 62.220USD 88,912 65.81
2025-05-05BUY1,11662.11062.800 62.731USD 70,008 65.87
2025-05-02BUY1,11662.53062.870 62.836USD 70,125 65.92
2025-05-01BUY1,11662.03062.640 62.579USD 69,838 65.97
2025-04-30BUY1,11662.66062.870 62.849USD 70,139 66.02
2025-04-29BUY1,11660.43060.720 60.691USD 67,731 66.11
2025-04-28BUY1,10559.52059.600 59.592USD 65,849 66.21
2025-04-25BUY1,10559.16059.210 59.205USD 65,422 66.32
2025-04-24BUY1,10558.97059.050 59.042USD 65,241 66.44
2025-04-23BUY1,10558.00059.010 58.909USD 65,094 66.57
2025-04-22BUY1,10557.38058.040 57.974USD 64,061 66.72
2025-04-21BUY1,10556.80058.230 58.087USD 64,186 66.89
2025-04-18BUY1,105 58.210* 67.03
2025-04-17BUY1,10558.21058.690 58.642USD 64,799 67.19
2025-04-16BUY1,10557.73058.780 58.675USD 64,836 67.35
2025-04-15BUY1,10558.46059.950 59.801USD 66,080 67.51
2025-04-14BUY1,10559.22059.300 59.292USD 65,518 67.66
2025-04-11BUY1,10556.87057.070 57.050USD 63,040 67.86
2025-04-10BUY1,10555.17058.330 58.014USD 64,105 68.10
2025-04-09BUY1,11958.86059.370 59.319USD 66,378 68.28
2025-04-08BUY1,06456.97061.470 61.020USD 64,925 68.50
2025-04-07BUY1,06460.29061.060 60.983USD 64,886 68.67
2025-04-04BUY1,06760.58063.570 63.271USD 67,510 68.83
2025-04-02BUY1,05662.33062.530 62.510USD 66,011 68.97
2025-04-01BUY1,05660.91062.000 61.891USD 65,357 69.14
2025-03-31BUY1,56560.55060.810 60.784USD 95,127 69.32
2025-03-28BUY1,56560.60060.970 60.933USD 95,360 69.52
2025-03-27BUY1,56560.68061.640 61.544USD 96,316 69.72
2025-03-26BUY1,57961.26062.880 62.718USD 99,032 69.92
2025-03-25BUY1,50462.08063.270 63.151USD 94,979 70.10
2025-03-24BUY1,50462.78063.310 63.257USD 95,139 70.28
2025-03-21BUY1,50461.92062.330 62.289USD 93,683 70.49
2025-03-20BUY1,50460.58061.750 61.633USD 92,696 70.74
2025-03-19BUY1,50760.34061.150 61.069USD 92,031 71.02
2025-03-18BUY1,49260.00061.030 60.927USD 90,903 71.31
2025-03-17BUY1,49262.01063.450 63.306USD 94,453 71.57
2025-03-14BUY1,50067.86068.120 68.094USD 102,141 71.68
2025-03-13BUY1,45567.71068.970 68.844USD 100,168 71.80
2025-03-12BUY1,45567.73068.230 68.180USD 99,202 71.92
2025-03-11BUY1,45568.07071.650 71.292USD 103,730 72.04
2025-03-10BUY1,45571.13071.890 71.814USD 104,489 72.07
2025-03-07BUY1,45570.79072.810 72.608USD 105,645 72.11
2025-03-05BUY1,45569.81069.970 69.954USD 101,783 72.19
2025-03-04BUY1,45569.68070.000 69.968USD 101,803 72.28
2025-03-03BUY1,20370.26073.450 73.131USD 87,977 72.36
2025-02-28BUY1,20373.50073.630 73.617USD 88,561 72.31
2025-02-27BUY1,20373.18074.600 74.458USD 89,573 72.28
2025-02-26BUY1,21174.30075.310 75.209USD 91,078 72.19
2025-02-25BUY1,17274.40076.240 76.056USD 89,138 72.10
2025-02-24BUY1,17274.01074.360 74.325USD 87,109 72.01
2025-02-21BUY1,17272.11072.970 72.884USD 85,420 72.00
2025-02-20BUY1,17271.38071.520 71.506USD 83,805 72.04
2025-02-19BUY1,17270.16071.430 71.303USD 83,567 72.13
2025-02-18BUY1,17271.27071.680 71.639USD 83,961 72.18
2025-02-17BUY887 70.420* 72.29
2025-02-14BUY88770.42071.800 71.662USD 63,564 72.40
2025-02-13BUY88770.01072.690 72.422USD 64,238 72.56
2025-02-12BUY88769.05069.100 69.095USD 61,287 72.81
2025-02-11BUY88766.33068.690 68.454USD 60,719 73.31
2025-02-10BUY89368.30073.420 72.908USD 65,107 73.73
2025-02-07BUY87174.13076.960 76.677USD 66,786 73.69
2025-02-06BUY87174.95075.490 75.436USD 65,705 73.57
2025-02-05BUY87175.26075.740 75.692USD 65,928 73.38
2025-02-04BUY87174.12074.920 74.840USD 65,186 73.29
2025-02-03BUY37673.74075.000 74.874USD 28,153 73.22
2025-01-31BUY37674.16075.180 75.078USD 28,229 73.07
2025-01-30BUY37673.77074.560 74.481USD 28,005 72.93
2025-01-29BUY37673.72074.110 74.071USD 27,851 72.73
2025-01-27BUY672.64073.430 73.351USD 440 72.56
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INCY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19321,923395451,11071.4%
2025-09-18244,9471,423469,74752.1%
2025-09-17277,858779546,95350.8%
2025-09-16359,781946576,37962.4%
2025-09-15347,4534582,22859.7%
2025-09-12353,0400631,53455.9%
2025-09-11448,7333,894739,70160.7%
2025-09-10490,727248671,93273.0%
2025-09-09515,3951,822682,79175.5%
2025-09-08308,184119479,82864.2%
2025-09-05256,7192,505512,04950.1%
2025-09-04422,6241,507834,71750.6%
2025-09-03381,6797,777624,92261.1%
2025-09-02547,12015,396816,26767.0%
2025-08-29148,294262304,42748.7%
2025-08-28164,0080347,48047.2%
2025-08-27248,926453513,40148.5%
2025-08-26365,1306709,32051.5%
2025-08-25478,1301,306642,31974.4%
2025-08-22344,3522,023596,30157.7%
2025-08-21198,7294,881335,30159.3%
2025-08-20351,6993,977555,34563.3%
2025-08-19343,1103,146574,32859.7%
2025-08-18366,1244,996653,10356.1%
2025-08-15480,8858,035625,79776.8%
2025-08-14593,55436,654806,06873.6%
2025-08-13845,18198,1601,257,50367.2%
2025-08-12462,89642,208678,68968.2%
2025-08-11385,211696595,89264.6%
2025-08-08248,925738426,18758.4%
2025-08-07268,864929420,48663.9%
2025-08-06554,642891731,48475.8%
2025-08-05361,6872,092623,87958.0%
2025-08-04338,0051,464519,15065.1%
2025-08-01414,814828572,87972.4%
2025-07-31570,8456,148777,41773.4%
2025-07-30471,30314,166881,19453.5%
2025-07-29966,64010,5811,593,70160.7%
2025-07-28382,23662625,51061.1%
2025-07-25216,96749422,99051.3%
2025-07-24348,27623528,51765.9%
2025-07-23297,903583487,29761.1%
2025-07-22267,987172446,48960.0%
2025-07-21223,626380406,72955.0%
2025-07-18241,218108471,58951.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.